Sivik Global Healthcare LLC Invests $6.32 Million in UnitedHealth Group Incorporated (NYSE:UNH)

Sivik Global Healthcare LLC bought a new position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) during the fourth quarter, according to the company in its most recent filing with the SEC. The firm bought 12,500 shares of the healthcare conglomerate's stock, valued at approximately $6,323,000. UnitedHealth Group accounts for approximately 3.3% of Sivik Global Healthcare LLC's investment portfolio, making the stock its 8th biggest holding.

Several other institutional investors have also added to or reduced their stakes in the business. Kathleen S. Wright Associates Inc. purchased a new position in shares of UnitedHealth Group in the third quarter valued at about $27,000. AlphaMark Advisors LLC bought a new position in UnitedHealth Group during the 4th quarter valued at approximately $30,000. Global Wealth Strategies & Associates grew its position in shares of UnitedHealth Group by 152.4% in the 3rd quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate's stock worth $31,000 after buying an additional 32 shares during the last quarter. West Financial Advisors LLC purchased a new stake in UnitedHealth Group in the third quarter worth $32,000. Finally, Quarry LP increased its position in UnitedHealth Group by 132.1% during the 2nd quarter. Quarry LP now owns 65 shares of the healthcare conglomerate's stock valued at $33,000 after purchasing an additional 37 shares during the period. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several equities analysts recently issued reports on UNH shares. Piper Sandler reduced their price target on shares of UnitedHealth Group from $605.00 to $600.00 and set an "overweight" rating on the stock in a research report on Thursday, January 2nd. Cantor Fitzgerald restated an "overweight" rating and issued a $700.00 target price on shares of UnitedHealth Group in a research note on Friday, January 17th. Hsbc Global Res upgraded UnitedHealth Group from a "hold" rating to a "strong-buy" rating in a report on Friday, January 10th. UBS Group reduced their target price on shares of UnitedHealth Group from $680.00 to $650.00 and set a "buy" rating on the stock in a research report on Wednesday, October 16th. Finally, Truist Financial cut their price objective on shares of UnitedHealth Group from $625.00 to $610.00 and set a "buy" rating on the stock in a report on Monday, January 6th. One equities research analyst has rated the stock with a hold rating, twenty have given a buy rating and two have issued a strong buy rating to the company's stock. According to MarketBeat, the company presently has a consensus rating of "Buy" and a consensus price target of $629.32.

Insider Transactions at UnitedHealth Group

In related news, Director Timothy Patrick Flynn acquired 1,000 shares of the stock in a transaction dated Friday, January 17th. The shares were purchased at an average cost of $511.57 per share, with a total value of $511,570.00. Following the transaction, the director now directly owns 4,500 shares in the company, valued at approximately $2,302,065. This represents a 28.57 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Corporate insiders own 0.33% of the company's stock.

UnitedHealth Group Stock Performance

Shares of NYSE UNH traded up $7.19 during trading on Thursday, reaching $545.29. 2,924,027 shares of the company traded hands, compared to its average volume of 4,584,902. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. The firm has a 50 day simple moving average of $538.18 and a 200-day simple moving average of $565.09. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $630.73. The stock has a market capitalization of $501.82 billion, a PE ratio of 35.18, a P/E/G ratio of 1.41 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating the consensus estimate of $6.74 by $0.07. The firm had revenue of $100.81 billion for the quarter, compared to analysts' expectations of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company's revenue was up 6.8% compared to the same quarter last year. During the same period in the prior year, the firm earned $5.83 EPS. Equities research analysts anticipate that UnitedHealth Group Incorporated will post 29.74 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, December 17th. Investors of record on Monday, December 9th were given a dividend of $2.10 per share. The ex-dividend date was Monday, December 9th. This represents a $8.40 annualized dividend and a yield of 1.54%. UnitedHealth Group's dividend payout ratio (DPR) is 54.19%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.